![app-icon app-icon](https://download.cergentis.com/hs-fs/hubfs/app-icon.png?width=200&height=192&name=app-icon.png)
Efficient multiplexed targeted gene editing as a strategy to generate improved CHO host cell lines for biotherapeutic manufacturing applications
In this joint white paper, we describe a fruitful collaboration with Horizon Discovery, where our proprietary TLA-based solutions were applied to several clones in order to characterize the genetic outcomes of a multiplex gene editing strategy (i.e. simultaneous knock-out of four genes in Chinese Hamster Ovary (CHO) cells via CRISPR-Cas9). Download this paper to learn how our genetic QC solutions enable comprehensive and unbiased evaluations of gene-editing outcomes, and how our assays deliver all essential genetic characteristics in a single experiment.
![Front_Horizon_Cergentis_whitepaper_2022 Front_Horizon_Cergentis_whitepaper_2022](https://download.cergentis.com/hs-fs/hubfs/Front_Horizon_Cergentis_whitepaper_2022.png?width=250&height=314&name=Front_Horizon_Cergentis_whitepaper_2022.png)